Oregon Issues First Psilocybin Manufacturing License
Tue / Mar 28th
Oregon’s first psilocybin licensee, Satori Farms PDX, received its license to begin manufacturing psilocybin products last week.
Psychedelics like psilocybin have been decriminalized in cities like Denver, causing the news to look more deeply at the possible benefits of the plants. Read news and stories about psychedelics in this section:
Tue / Mar 28th
Oregon’s first psilocybin licensee, Satori Farms PDX, received its license to begin manufacturing psilocybin products last week.
Tue / Mar 21st
The Psychedelic Medicine PAC is a newly-formed political action committee that will back candidates who support the use of psychedelics for therapeutic purposes.
Tue / Mar 7th
Canadian cannabis company Adastra Holdings Ltd. said it received Health Canada approval to add psilocybin, psilocin, and cocaine to its substance dealer’s license.
Tue / Feb 7th
Australia’s Therapeutic Goods Administration announced the legalization of medical psilocybin and MDMA for depression and PTSD, respectively, starting July 1.
Tue / Jan 3rd
Oregon’s voter-approved psilocybin therapy reforms took effect on January 1. As the first such reforms in the US, they establish psilocybin therapy centers where anyone 21+ can consume psychedelic mushrooms in a supervised setting.
Thu / Dec 29th
Psychedelics including psilocybin, DMT, ibogaine, and mescaline are now legal at the state level for Colorado adults aged 21 or older.
Mon / Dec 19th
California state Sen. Scott Wiener is set to propose a bill that would decriminalize the possession of psilocybin mushrooms and DMT statewide.
Thu / Dec 15th
In the second installment of our 2023 predictions series, we asked experts in cannabis science, cultivation, and agricultural technology — as well as industrial hemp and psychedelics — to weigh in with their industry expectations for the next year.
Fri / Dec 2nd
Berkeley, California city officials advanced a psychedelics decriminalization proposal this week despite concerns by some reform advocates that the proposal does not go far enough to deprioritize law enforcement actions.
Mon / Nov 21st
A bipartisan proposal by Sens. Cory Booker (D-NJ) and Rand Paul (R-KY) would improve research opportunities for psychedelics by rescheduling any drugs given a “breakthrough therapy” designation by the FDA.
Thu / Nov 17th
A nearly 70% majority of Oregon counties have voted to ban psilocybin access in response to the state’s 2020 medical psilocybin legalization vote.
Fri / Nov 11th
Colorado voters passed the legalization of psychedelic mushrooms on Tuesday; the move will let people aged 21 or older grow and share psychedelic mushrooms and will establish state-regulated “healing centers” where people can make appointments to consume psilocybin in a controlled environment.
Wed / Nov 9th
The result of the ballot initiative to decriminalize and regulate psychedelics in Colorado is still too close to call the day after Tuesday’s elections.
Thu / Oct 27th
Six municipalities in Oregon will vote in the midterm elections on whether to ban the use and production of psychedelics within their jurisdictions.
Mon / Oct 17th
Voters in Colorado will vote next month on the legalization of psilocybin and psilocin for therapeutic purposes.
Mon / Aug 29th
Multiple Oregon municipalities are planning to put psilocybin therapy bans on November election ballots after state voters opted to legalize the treatment in 2020.
Tue / Aug 23rd
A federal survey found that U.S. young adults aged 19 to 30 used more cannabis and hallucinogens in 2021 than in any previous year.
Thu / Aug 18th
The Zide Chruch of Entheogenic Plants, a church in Oakland, California that uses cannabis and psychedelics as communion, has filed a lawsuit against the city and its police department over a 2020 raid of their site.
Fri / Aug 5th
In a recent podcast interview, Green Bay Packers quarterback Aaron Rodgers credited the psychedelic ayahuasca for what he called “the best season” of his career.
Tue / Jul 19th SPOTLIGHT
Iboga, Kambo, and other Sacred Earth Medicines which facilitate consciousness-expanding experiences have long been a part of indigenous medicine around… Read More
Thu / Jul 7th
Filament Health has begun its Phase 1 study investigating naturally-derived psilocin and psilocybin, the first such study ever approved by the FDA.
Wed / Jul 6th
New York Rep. Alexandria Ocasio-Cortez introduced an amendment this week to the 2023 National Defense Authorization Act that would require the Department of Defense to study the therapeutic potential of psychedelics for veterans.
Wed / Jun 22nd INTERVIEW
Kim Stuck is the founder of Allay Consulting, a hemp, cannabis, and psychedelics compliance consultant firm.
Wed / Jun 1st INTERVIEW
Matthew X. Lowe, Ph.D., is the Research Director for Realm of Caring — a cannabis non-profit focused on increasing access to cannabis medicine — and Research Director for Unlimited Sciences, a psychedelics research non-profit.
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.